logo
Plus   Neg
Share
Email

NY Regulator Investigates Goldman Sachs' Apple Card For Alleged Gender Bias

The New York Department of Financial Services has opened an investigation into claims the Apple Card, which is administered by Goldman Sachs, offered different credit limits for men and women.

The investigation follows complaints - including from Apple's co-founder Steve Wozniak - that algorithms used to set limits might be inherently biased against women.

The tech entrepreneur David Heinmeier Hansson twitted that Apple Card offered him twenty times the credit limit as his wife, although they have shared assets and she has a higher credit score. Hansson also twitted that after reaching out to Apple in an attempt to rectify the situation, he was told credit limits are determined by an algorithm.

The New York Department of Financial Services said in a statement that it "will be conducting an investigation to determine whether New York law was violated and ensure all consumers are treated equally regardless of sex. Any algorithm that intentionally or not results in discriminatory treatment of women or any other protected class violates New York law."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. (EBAY) Wednesday reported a fourth-quarter profit that trumped Wall Street analysts' estimates, as did revenues. However, shares of the company slipped over 5% after the company issued a weak outlook for the first quarter. eBay's fourth-quarter profit dropped to $558 million or $0.69 per... Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry.
Follow RTT
>